Abstract
The persistent lung inflammation results in inhaled toxic dusts bring pathologic changes in airway system that lead to development of chronic obstructive pulmonary disease (COPD). Recently, beyond local inflammation in lung, COPD is regarded as chronic systemic inflammatory disease linked to extra pulmonary disease. Therefore, several local and systemic inflammatory biomarkers were needed to be investigated for understanding of COPD. Hence, this current study was aimed to identify the association between COPD and inflammatory biomarkers in workers exposed to inorganic dusts. Clara cell secretary proteins (CC-16) and surfactant protein D (SP-D) were chosen as local inflammatory biomarker, high sensitive Creactive protein (hsCRP), interleukin (IL)-6, serum amyloid protein A (SAA) and tyrosine lysine leucine 40 (YKL-40) were chosen as systemic inflammatory markers in 39 COPD and 39 control group. In current study, CC-16, hsCRP and YKL-40 were linked to COPD in conditional logistic regression model. Furthermore, CC-16 and hsCRP are related to COPD independently to working duration and smoking history. These results suggest that local and inflammatory biomarker could be independent predictor of COPD in worker exposed to inorganic dusts.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Hnizdo, E. & Vallyathan, V. Chronic obstructive pulmonary disease due to occupational exposure to silica dust: a review of epidemiological and pathological evidence. Occup. Environ. Med. 60, 237–243 (2003).
Bergdahl, I. A. et al. Increased mortality in COPD among construction workers exposed to inorganic dust. Eur. Respir. J. 23, 402–406 (2004).
Rabe, K. F. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 176, 532–555 (2007).
van Eeden, S. F. & Sin, D. D. Chronic obstructive pul-Chronic Obstructive Pulmonary Disease and Inflammatory Biomarkers 89 monary disease: a chronic systemic inflammatory disease. Respiration 75, 224–238 (2008).
Jones, P. W. & Agusti, A. G. Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur. Respir. J. 27, 822–832 (2006).
Kelly, E., Owen, C. A., Pinto-Plata, V. & Celli, B. R. The role of systemic inflammatory biomarkers to predict mortality in chronic obstructive pulmonary disease. Expert Rev. Respir. Med. 7, 57–64 (2013).
Braido, F. et al. Clara cell 16 protein in COPD sputum: a marker of small airways damage? Respir. Med. 101, 2119–2124 (2007).
Lomas, D. A. et al. Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort. Thorax 63, 1058–1063 (2008).
Agusti, A. et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One 7, e37483 (2012).
He, J. Q. et al. Associations of IL6 polymorphisms with lung function decline and COPD. Thorax 64, 698–704 (2009).
Nillawar, A. N., Bardapurkar, J. S. & Bardapurkar, S. J. High sensitive C-reactive protein as a systemic inflammatory marker and LDH-3 isoenzyme in chronic obstructive pulmonary disease. Lung India 29, 24–29 (2012).
Korfhagen, T. R. et al. Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo. J. Biol. Chem. 273, 28438–28443 (1998).
Barnes, P. J. et al. Pulmonary biomarkers in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 174, 6–14 (2006).
Stockley, R. A. Biomarkers in COPD: time for a deep breath. Thorax 62, 657–660 (2007).
Umland, T. C. et al. Structure of a human Clara cell phospholipid-binding protein-ligand complex at 1.9 A resolution. Nat. Struct. Mol. Biol. 1, 538–545 (1994).
Yoneda, K. Ultrastructural localization of phospholipases in the Clara cell of the rat bronchiole. Am. J. Pathol. 93, 745–752 (1978).
Van Vyve, T. et al. Protein content in bronchoalveolar lavage fluid of patients with asthma and control subjects. J. Allergy Clin. 95, 60–68 (1995).
Mattsson, J., Remberger, M., Andersson, O., Sundberg, B. & Nord, M. Decreased serum levels of clara cell secretory protein (CC16) are associated with bronchiolitis obliterans and may permit early diagnosis in patients after allogeneic stem-cell transplantation. Transplantation 79, 1411–1416 (2005).
Shijubo, N. et al. Clara cell protein-positive epithelial cells are reduced in small airways of asthmatics. Am. J. Respir. Crit. Care Med. 160, 930–933 (1999).
Bernard, A., Marchandise, F. X., Depelchin, S., Lauwerys, R. & Sibille, Y. Clara cell protein in serum and bronchoalveolar lavage. Eur. Respir. J. 5, 1231–1238 (1992).
Pilette, C. et al. Reduced epithelial expression of secretory component in small airways correlates with airflow obstruction in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 163, 185–194 (2001).
Honda, Y. et al. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am. J. Respir. Crit. Care Med. 152, 1860–1866 (1995).
Ohnishi, H. et al. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am. J. Respir. Crit. Care Med. 165, 378–381 (2002).
Lomas, D. A. et al. Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD. Eur. Respir. J. 34, 95–102 (2009).
Winkler, C. et al. Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD. Respir. Res. 12, 29 (2011).
Yildiz, F., Basyigit, I., Yildirim, E., Boyaci, H. & Ilgazli, A. Does addition of inhaled steroid to combined bronchodilator therapy affect health status in patients with COPD? Respirology 9, 352–355 (2004).
Pommer, P. [Peer-reviewed study: COPD — increases risk of pneumonia in early steroid therapy]. Pneumologie 64, 720 (2010).
Akl, E. A., Grant, B. J., Guyatt, G. H., Montori, V. M. & Schunemann, H. J. A decision aid for COPD patients considering inhaled steroid therapy: development and before and after pilot testing. BMC medical informatics and decision making 7, 12 (2007).
Cano, N. J. et al. C-reactive protein and body mass index predict outcome in end-stage respiratory failure. Chest 126, 540–546 (2004).
Dev, D. et al. Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease. Respir. Med. 92, 664–667 (1998).
Sin, D. D., Lacy, P., York, E. & Man, S. F. Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 170, 760–765 (2004).
Ridker, P. M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107, 363–369 (2003).
Hansell, A. L., Walk, J. A. & Soriano, J. B. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur. Respir. J. 22, 809–814 (2003).
Broekhuizen, R., Wouters, E. F., Creutzberg, E. C. & Schols, A. M. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 61, 17–22 (2006).
Bozinovski, S. et al. Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 177, 269–278 (2008).
Sapey, E. & Stockley, R. A. COPD exacerbations. 2: aetiology. Thorax 61, 250–258 (2006).
Boot, R. G. et al. Strong induction of members of the chitinase family of proteins in atherosclerosis: chito-triosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscle. Thromb. Vasc. Biol. 19, 687–694 (1999).
Chupp, G. L. et al. A chitinase-like protein in the lung and circulation of patients with severe asthma. N. Engl. J. Med. 357, 2016–2027 (2007).
Yoon, J.-H. et al. Association between impaired lung function and coronary artery calcium score in workers exposed to inorganic dust. Toxicol. Environ. Health Sci. 4, 139–142 (2012).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hwang, J.H., Yoon, JH., Shin, J. et al. Chronic obstructive pulmonary disease and inflammatory biomarkers in retired workers exposed to inorganic dusts. Toxicol. Environ. Health Sci. 5, 86–91 (2013). https://doi.org/10.1007/s13530-013-0162-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13530-013-0162-9